SYAMS

Serial Number 97146925
733

Registration Progress

Application Filed
Nov 29, 2021
Under Examination
Dec 6, 2022
Approved for Publication
Oct 11, 2022
Published for Opposition
Oct 11, 2022
Registered

Trademark Image

SYAMS

Basic Information

Serial Number
97146925
Filing Date
November 29, 2021
Published for Opposition
October 11, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Oct 28, 2024
Application
Pending
Classes
042

Rights Holder

Biohaven Therapeutics Ltd.

99
Address
Ritter House, P.O. Box 173
Road Town, Tortola VG1110
VG

Ownership History

Biohaven Therapeutics Ltd.

Original Applicant
99
New Haven, CT

Biohaven Therapeutics Ltd.

Owner at Publication
99
Road Town, Tortola VG

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description Documents
Oct 28, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 28, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 28, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 28, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 23, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
May 23, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 23, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 12, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 12, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 17, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 17, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 7, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 5, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 5, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 5, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 6, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 11, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 11, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 21, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 7, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 2, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Classification

International Classes
042